Latest Health News
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of64Cu-PSMA-I&T for Prostate Cancer in Japan
PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Curium Group announced today that…
argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential…
Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe
BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received…
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
October 14, 2025 08:05 ET | Source: Candel Therapeutics NEEDHAM, Mass., Oct.…
HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms
New Offerings Bring Millions Affordable Healthcare Solutions During Open Enrollment Season October…
CytoMed makes cash bid for potential acquisition of TC BioPharm Limiteds relevant assets
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC)…
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET…
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE)…
Press release: Transparency Notification from Shareholder
Transparency Notification from Shareholder Ghent, Belgium – 13 October 2025 – Sequana…
